We are entering a new era of cancer treatment. The steady progress medicine has made in reducing the overall mortality of this disease—one so dreaded that people feared to utter its name lest they conjure the condition—is likely to accelerate in the years ahead. As ample funding meets burgeoning breakthroughs and broader, better screening, the decades-long war on cancer is taking a significant toll on the disease. What was once a six-letter death sentence may one day turn into a chronic condition.
Lovely though this vision may be, it is not assured. Oncology is at a crossroads. The cost to end the scourge of cancer is enormous, while the people necessary to accomplish this feat are both unhappy and in short supply. Despite overall improvements, individual outcomes remain stubbornly unequal as is representation, and our own behaviors are fueling cancer’s pervasiveness.
Download the White Paper